← All diseases Infectious diseases

Chronic hepatitis B

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest evidence only (82)Meta-analysis (26)Treatment guideline (6)Randomized trial (32)Systematic review (10)Phase 3 study (8)Clinical trial (630)Review article (169)Early study (phase 1 or 2) (25)Case reports (96)Laboratory or animal research (16)Commentary or Editorial (50)Retracted publication (2) Studies currently recruiting participants only (31)

Filter

Publications and studies (2004)

• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Chronic hepatitis B clinically attains cure by applying a timely adjustment to a medication regimen's twists and turns: a case report]. (2024/11/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [A case of chronic hepatitis B with low-level viremia treated with tenofovir amibufenamide]. (2024/11/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Tenofovir amibufenamide treatment in a case of hepatitis B virus-related decompensated liver cirrhosis]. (2024/11/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [A case of successful treatment of acute exacerbation of chronic hepatitis B combined with abnormally elevated alpha-fetoprotein]. (2024/11/30) ♡
• [Real-world data of tenofovir amibufenamide therapy for treatment-naïve patients with chronic hepatitis B]. (2024/11/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [A case of persistent low-level viremia treated with tenofovir amibufenamide]. (2024/11/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [A case of chronic hepatitis B with low-level viremia treated with sequential treatment of tenofovir amibufenamide]. (2024/11/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [A case of complete viral suppression after switching to tenofovir amibufenamide treatment with chronic hepatitis B and concomitant impaired renal function]. (2024/11/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Tenofovir amibufenamide treatment for three cases with chronic hepatitis B]. (2024/11/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Two cases of patients with hepatitis B e antigen-positive chronic hepatitis B initially treated with tenofovir amibufenamide]. (2024/11/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [A case of treated chronic hepatitis B reducing viral load with tenofovir amibufenamide treatment]. (2024/11/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [A case of chronic hepatitis B in the treatment of tenofovir amibufenamide]. (2024/11/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [A case of chronic hepatitis B with a high viral load treated with tenofovir amibufenamide]. (2024/11/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [A case of decompensated hepatitis B virus-related cirrhosis combined with renal injury rescue treatment using tenofovir amibufenamide tablet]. (2024/11/30) ♡
• Prevalence and Risk Factors of Significant Hepatic Fibrosis in Omani Patients with HBeAg-negative Chronic Hepatitis B Virus Infection: A Retrospective Study. (2024/11/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Clinical management of hypophosphatemic osteomalacia induced by adefovir and tenofovir: Insights from a case report. (2024/11/29) ♡
• Reply to: "Understanding virologic heterogeneity in chronic hepatitis B treatment". (2024/11/29) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Portocaval shunts' role in gut microbiota and hepatic encephalopathy: The gut-to-brain pathway. (2024/11/21) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hepatitis B Virus Treatment in Children: Common Challenges and Management Options in a Case-Based Format. (2024/11/21) ♡
• Patients with chronic hepatitis B under nucleos(t)ide analog therapy with Omicron BA.5 infection: A retrospective study in South China. (2024/11/20) ♡
• New Window Into Hepatitis B in Africa: Liver Sampling Combined With Single-Cell Omics Enables Deep and Longitudinal Assessment of Intrahepatic Immunity in Zambia. (2024/11/15) ♡
• Machine-learning methodologies to predict disease progression in chronic hepatitis B in Africa. (2024/11/15) ♡
• Hepatitis D virus infection triggers CXCL9-11 upregulation in hepatocytes and liver infiltration of CXCR3+ CD4 T cells. (2024/11/14) ♡
• Lower incidence of hepatocellular carcinoma with tenofovir alafenamide in chronic hepatitis B: Evidence from a large-scale cohort. (2024/11/12) ♡
• Clinical effects of combined treatment of traditional Chinese medicine and western medicine for viral hepatitis B cirrhosis and the effects on serum miR-122, miR-200a. (2024/11/01) ♡
• Asiatic acid inhibits HBV cccDNA transcription by promoting HBx degradation. (2024/10/28) ♡
• Hepatitis Delta Virus Testing, Prevalence, and Liver-Related Outcomes Among US Veterans With Chronic Hepatitis B. (2024/10/25) ♡
• Host cytokine genetic polymorphisms in a selected population of persons living with hepatitis B virus infection in the central region of Ghana. (2024/10/22) ♡
• Understanding virologic heterogeneity in chronic hepatitis B treatment. (2024/10/19) ♡
• Clinical audit of quality of care among patients with viral hepatitis in primary care in a low endemic region. (2024/10/08) ♡
• New dimension in viral hepatitis research. (2024/10/02) ♡
• Autophagy Gene BECN1 Intronic Variant rs9890617 Predisposes Individuals to Hepatitis B Virus Infection. (2024/10/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Exploring the mechanism of action of Chinese medicine in regulating liver fibrosis based on the alteration of glucose metabolic pathways. (2024/10/01) ♡
• Treatment guidelineiAn official agreement between doctors about how this disease should be treated. This is not a single study but the conclusion of an entire medical field. AGA Clinical Practice Update on Pregnancy-Related Gastrointestinal and Liver Disease: Expert Review. (2024/10/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. [Acceptability and screening outcomes for hepatitis B, C and human immunodeficiency virus using rapid diagnostic tests in patients undergoing outpatient endoscopy]. (2024/10/01) ♡
• A Comprehensive Analysis of Inactive Hepatitis B Infection in a Cohort of Omani Patients. (2024/09/30) ♡
• Prevention, Diagnosis, and Treatment of Hepatocellular Carcinoma. (2024/09/24) ♡
• An Experimental Animal Study: Electroacupuncture Facilitates Antiviral Immunity Against Hepatitis B Virus Through the IFN-γ/JAK/STAT Axis. (2024/09/19) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02). (2024/09/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Nucleos(t)ide Analog Treatment Discontinuation in Chronic Hepatitis B Virus Infection: A Systematic Literature Review. (2024/08/23) ♡
• Identification and validation of plasma AGRN as a novel diagnostic biomarker of hepatitis B Virus-related chronic hepatitis and liver fibrosis/cirrhosis. (2024/08/01) ♡
• Potential role of Vitamin D in immune response in patients with viral hepatitis. (2024/08/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Modified by the Innovative Drugs and Strategies-Pattern of Selected Indications for Pediatric Liver Transplantation. (2024/08/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. mTOR Signaling: Roles in Hepatitis B Virus Infection and Hepatocellular Carcinoma. (2024/08/01) ♡
• Serum IP-10 increase correlated with PEG-IFNα response in nucleot(s)ide analogs-treated patients with chronic hepatitis B. (2024/07/29) ♡
• Hepatocellular Carcinoma with Vascular and Cardiac Involvement in a Young Patient with Non-Cirrhotic Hepatitis B: A Case Report. (2024/07/26) ♡
• Long-term hepatitis B surface antigen kinetics after nucleos(t)ide analog discontinuation in patients with noncirrhotic chronic hepatitis B. (2024/07/06) ♡
• Disease severity and antiviral response in patients with chronic hepatitis B with non-obese NAFLD. (2024/07/01) ♡
• Association Between Serum Levels of Anti-heat Shock Protein 27 Antibody and Liver Cell Injury in Chronic Hepatitis B. (2024/07/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Reply to: "Ultrasensitive HBsAg testing predicts HBsAg seroreversion outcomes: Considerations for new and existing therapies". (2024/07/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.